Evidence-Based Medicine Guidelines
Dipeptidyl peptidase-4 (DPP-4) inhibitors for type 2 diabetes mellitus
Dipeptidyl peptidase-4 (DPP-4) inhibitors for type 2 diabetes mellitus is a topic covered in the Evidence-Based Medicine Guidelines.
To view the entire topic, please log in or purchase a subscription.
Evidence Central is an integrated web and mobile solution that helps clinicians quickly answer etiology, diagnosis, treatment, and prognosis questions using the latest evidence-based research. Explore these free sample topics:
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Dipeptidyl Peptidase-4 (DPP-4) Inhibitors for Type 2 Diabetes Mellitus." Evidence-Based Medicine Guidelines, Duodecim Medical Publications Limited, 2019. Evidence Central, evidence.unboundmedicine.com/evidence/view/EBMG/453802/all/Dipeptidyl_peptidase_4__DPP_4__inhibitors_for_type_2_diabetes_mellitus.
Dipeptidyl peptidase-4 (DPP-4) inhibitors for type 2 diabetes mellitus. Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2019. https://evidence.unboundmedicine.com/evidence/view/EBMG/453802/all/Dipeptidyl_peptidase_4__DPP_4__inhibitors_for_type_2_diabetes_mellitus. Accessed July 5, 2022.
Dipeptidyl peptidase-4 (DPP-4) inhibitors for type 2 diabetes mellitus. (2019). In Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited. https://evidence.unboundmedicine.com/evidence/view/EBMG/453802/all/Dipeptidyl_peptidase_4__DPP_4__inhibitors_for_type_2_diabetes_mellitus
Dipeptidyl Peptidase-4 (DPP-4) Inhibitors for Type 2 Diabetes Mellitus [Internet]. In: Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2019. [cited 2022 July 05]. Available from: https://evidence.unboundmedicine.com/evidence/view/EBMG/453802/all/Dipeptidyl_peptidase_4__DPP_4__inhibitors_for_type_2_diabetes_mellitus.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Dipeptidyl peptidase-4 (DPP-4) inhibitors for type 2 diabetes mellitus
ID - 453802
BT - Evidence-Based Medicine Guidelines
UR - https://evidence.unboundmedicine.com/evidence/view/EBMG/453802/all/Dipeptidyl_peptidase_4__DPP_4__inhibitors_for_type_2_diabetes_mellitus
PB - Duodecim Medical Publications Limited
DB - Evidence Central
DP - Unbound Medicine
ER -
